| FDMT Stock | | | USD 7.50 0.12 1.57% |
4D Molecular financial indicator trend analysis is way more than just evaluating 4D Molecular Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 4D Molecular Therapeutics is a good investment. Please check the relationship between 4D Molecular Pfcf Ratio and its Cash Per Share accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 4D Molecular Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
4D Molecular Therapeutics Pfcf Ratio account and
Cash Per Share. At this time, the significance of the direction appears to have pay attention.
The correlation between 4D Molecular's Pfcf Ratio and Cash Per Share is -0.74. Overlapping area represents the amount of variation of Pfcf Ratio that can explain the historical movement of Cash Per Share in the same time period over historical financial statements of 4D Molecular Therapeutics, assuming nothing else is changed. The correlation between historical values of 4D Molecular's Pfcf Ratio and Cash Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pfcf Ratio of 4D Molecular Therapeutics are associated (or correlated) with its Cash Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Per Share has no effect on the direction of Pfcf Ratio i.e., 4D Molecular's Pfcf Ratio and Cash Per Share go up and down completely randomly.
Correlation Coefficient | -0.74 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Most indicators from 4D Molecular's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 4D Molecular Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 4D Molecular Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
At this time, 4D Molecular's
Sales General And Administrative To Revenue is comparatively stable compared to the past year.
Enterprise Value is likely to gain to about 587.6
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 21.7
M in 2024.
When running 4D Molecular's price analysis, check to
measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to
predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.